4th Edition of International Heart Congress
June 22-24,2026 | Hybrid Event
Valvuloplasty
Valvuloplasty is a medical procedure designed to treat valvular heart disease, a condition characterized by dysfunction or narrowing of the heart valves. During valvuloplasty, a catheter equipped with a deflated balloon is threaded through blood vessels to the heart valve that requires intervention. Once in position, the balloon is inflated to widen the narrowed valve, improving blood flow and alleviating symptoms associated with valvular disorders. This minimally invasive procedure is often considered as an alternative to traditional open-heart surgery, offering reduced recovery times and less postoperative discomfort. Valvuloplasty has proven to be an effective intervention for select cases of valvular heart disease, providing patients with a viable option to restore cardiac function and enhance their overall quality of life.
Ahdy Wadie Helmy
Indiana University School of Medicine, United States
Narendra Kumar
HeartbeatsZ Academy, United Kingdom
Federico Benetti
Benetti Foundation, Argentina
Desislava Doycheva
Loma Linda University, United States
Uwe Peter Tigor
Auxilius Pharma, United States
Ishan Abdullah
George Washington University School of Medicine and Health Sciences, United States
Faizan Butt
Rutgers Jersey City Medical Center, United StatesSubmit your abstract Today
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Analysis of cardiovascular risk factors in patients with type 1 diabetes mellitus
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Beyond PCSK9: The next wave of lipid-lowering and thrombosis prevention - from bench to breakthrough
Narendra Kumar, HeartbeatsZ Academy, United Kingdom